Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
European Journal of Clinical Pharmacology|March 10, 2006
Investigation of sarizotan's impact on the pharmacokinetics of probe drugs for major cytochrome P450 isoenzymes: a combined cocktail trialSonja Krösser, Roland Neugebauer, Hugues Dolgos, et al.
Clinical Pharmacokinetics|August 2, 2018
Correction to: The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple SclerosisRobert Hermann, Mats O Karlsson, Ana M Novakovic, et al.
Clinical Pharmacokinetics|July 11, 2018
The Clinical Pharmacology of Cladribine Tablets for the Treatment of Relapsing Multiple SclerosisRobert Hermann, Mats O Karlsson, Ana M Novakovic, et al.
Clinical Pharmacokinetics|August 26, 2021
Review of Transporter Substrate, Inhibitor, and Inducer Characteristics of CladribineRobert Hermann, Peter Krajcsi, Markus Fluck, et al.
Clinical Pharmacokinetics|December 11, 2021
Cladribine as a Potential Object of Nucleoside Transporter-Based Drug InteractionsRobert Hermann, Peter Krajcsi, Markus Fluck, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 12, 2010
In vitro characterization of sarizotan metabolism: hepatic clearance, identification and characterization of metabolites, drug-metabolizing enzyme identification, and evaluation of cytochrome p450 inhibitionDieter Gallemann, Elmar Wimmer, Constance C Höfer, et al.
Pharmacology Research & Perspectives|April 13, 2016
In vitro and in vivo drug disposition of cilengitide in animals and humanHugues Dolgos, Achim Freisleben, Elmar Wimmer, et al.
Journal of Neuroimmunology|September 18, 2021
Pharmacodynamic biomarkers of long-term interferon beta-1a therapy in REFLEX and REFLEXIONMark S Freedman, Jérôme Wojcik, Kristina H Holmberg, et al.
Clinical Pharmacology and Therapeutics|February 28, 2024
Asia-Inclusive Global Development of Enpatoran: Results of an Ethno-Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical TrialLena Klopp-Schulze, Sathej Gopalakrishnan, Özkan Yalkinoglu, et al.
Oncoimmunology|September 6, 2021
Avelumab internalization by human circulating immune cells is mediated by both Fc gamma receptor and PD-L1 bindingHulin Jin, Vittorio D'Urso, Berend Neuteboom, et al.
Pageof 1